Autologous versus allogeneic mesenchymal stem cell therapy: The pros and cons

被引：4
|
作者：
Durand, Nisha [1 ,2 ]
Zubair, Abba C. [1 ,2 ,3 ]
机构：
[1] Mayo Clin, Ctr Regenerat Med, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL 32224 USA
[3] Mayo Clin Joint Venture, Sheikh Shakhbout Med City, Abu Dhabi, U Arab Emirates
来源：
SURGERY | 2022年 / 171卷 / 06期
关键词：
CRITICAL LIMB ISCHEMIA;
D O I：
10.1016/j.surg.2021.10.057
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1440 / 1442
页数：3
相关论文
共 50 条
  • [21] Pros and cons of stem cell transplantation for autoimmune disease
    Thomas, ED
    [J]. JOURNAL OF RHEUMATOLOGY, 1997, 24 : 100 - 102
  • [22] Autologous versus allogeneic stem cell transplant for multiple myeloma
    Arora, M
    McGlave, PB
    Burns, LJ
    Miller, JS
    Barker, JN
    Defor, TE
    Weisdorf, DJ
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 71 - 72
  • [23] Autologous mesenchymal stem cell therapy in myocardial infarction
    Liu, JB
    Hu, QS
    Mansoor, A
    Wang, ZG
    Zhang, JR
    Xu, C
    Zeng, LP
    Zhang, JY
    [J]. CIRCULATION, 2003, 108 (17) : 217 - 218
  • [24] AUTOLOGOUS MESENCHYMAL STEM CELL THERAPY IN BEHCET DISEASE
    Gabr, H.
    Elkheir, W. Abo
    Elkheir, Y. Abo
    [J]. CYTOTHERAPY, 2017, 19 (05) : S10 - S11
  • [25] The Pros and Cons of Adherent Versus Suspension Cell Culture
    Bilodeau, Ann Rossi
    [J]. BIOPHARM INTERNATIONAL, 2024, 37 (01) : 18 - 22
  • [26] Editorial: Autologous and Allogeneic Stem Cell Transplant in Cancer Therapy
    Sharma, Nidhi
    Efebera, Yvonne A.
    [J]. CANCERS, 2023, 15 (05)
  • [27] Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases
    Sanz-Ruiz, Ricardo
    Fernandez-Aviles, Francisco
    [J]. PHARMACOLOGICAL RESEARCH, 2018, 127 : 92 - 100
  • [28] Balancing Ethical Pros and Cons of Stem Cell Derived Gametes
    Seppe Segers
    Heidi Mertes
    Guido de Wert
    Wybo Dondorp
    Guido Pennings
    [J]. Annals of Biomedical Engineering, 2017, 45 : 1620 - 1632
  • [29] Pros and cons of multiple therapy
    Wilkinson, DG
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S415 - S416
  • [30] Glibenclamide therapy: pros and cons
    Vikulova, O. K.
    Shestakova, M. V.
    [J]. DIABETES MELLITUS, 2011, 14 (03): : 92 - 95
12345